Palo Alto, CA, United States of America

Hiroki Toda



Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2007-2010

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Hiroki Toda: Innovator in Stem Cell Research

Introduction

Hiroki Toda is a prominent inventor based in Palo Alto, CA (US). He has made significant contributions to the field of stem cell research, particularly in the development of neuron survival factors. With a total of 3 patents, his work has the potential to impact treatments for various neurological conditions.

Latest Patents

Toda's latest patents focus on human and mammalian stem cell-derived neuron survival factors. These inventions relate to polypeptides known as neuron survival factor polypeptides (SDNSF), which are derived from human, rat, and mouse stem cells. The patents detail a process for producing these polypeptides, cDNA encoding SDNSF, and vectors that comprise the cDNA. Additionally, they include host cells transformed by the vector, antibodies against SDNSF, and pharmaceutical compositions containing these components. The polypeptides are effective in promoting the survival of nerve cells, making them promising candidates for treating injuries to the central nervous system caused by conditions such as brain infarction, brain hemorrhage, and spinal cord injury.

Career Highlights

Throughout his career, Hiroki Toda has worked with notable companies, including Ono Pharmaceutical Co., Ltd. His research has led to advancements in understanding and utilizing stem cell technology for therapeutic purposes.

Collaborations

Toda has collaborated with esteemed colleagues such as Tasuku Honjo and Kei Tashiro, further enhancing the impact of his research in the scientific community.

Conclusion

Hiroki Toda's innovative work in stem cell-derived neuron survival factors positions him as a key figure in the advancement of treatments for neurological injuries and conditions. His contributions continue to pave the way for future research and therapeutic developments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…